E
ETHOS TECHNOLOGIES INC. CLASS A COMMON STOCK
NASDAQ: LIFE (Ethos Technologies Inc.)
最近更新时间: 2天之前, 6:03AM29.75
-0.84 (-2.75%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Insurance - Life (US) | 看跌 | 看跌 |
| Insurance - Life (全球的) | 看跌 | 混合的 | |
| 股票 | Ethos Technologies Inc. | 看跌 | 看跌 |
AIStockmoo 评分
-1.1
| 分析师共识 | -3.5 |
| 内部交易活动 | NA |
| 价格波动 | -3.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 2.0 |
| 平均 | -1.13 |
|
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis. |
|
| 部门 | Financial Services |
| 行业 | Insurance - Life |
| 投资方式 | Small Value |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 33.00 (Goldman Sachs, 10.92%) | 购买 |
| 中 | 19.00 (-36.13%) | |
| 低 | 13.00 (JP Morgan, -56.30%) | 购买 |
| 平均值 | 19.88 (-33.18%) | |
| 总计 | 8 购买 | |
| 平均价格@调整类型 | 11.22 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Citigroup | 26 Feb 2026 | 16.00 (-46.22%) | 购买 | 12.28 |
| 23 Feb 2026 | 15.00 (-49.58%) | 购买 | 11.00 | |
| Deutsche Bank | 24 Feb 2026 | 23.00 (-22.69%) | 购买 | 11.44 |
| B of A Securities | 23 Feb 2026 | 15.00 (-49.58%) | 购买 | 11.00 |
| Baird | 23 Feb 2026 | 18.00 (-39.50%) | 购买 | 11.00 |
| Barclays | 23 Feb 2026 | 20.00 (-32.77%) | 购买 | 11.00 |
| Citizens | 23 Feb 2026 | 21.00 (-29.41%) | 购买 | 11.00 |
| Goldman Sachs | 23 Feb 2026 | 33.00 (10.92%) | 购买 | 11.00 |
| JP Morgan | 23 Feb 2026 | 13.00 (-56.30%) | 购买 | 11.00 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合